Additional Topics in This Section
Molecular Medicine at Fox Chase
Read more »
Our research faculty
Read more »
Fox Chase Cancer Center and Lincoln University partner for cancer research and training.
Read more »
Researchers at Fox Chase investigate problems that range from understanding the fundamental mechanisms of biomolecular reactions all the way to the treatment of neoplastic diseases in the clinic.
The science is conducted with Fox Chase's commitment to research and interdisciplinary interaction. Current faculty research programs are wide-ranging and include:
Talbot Research Library
Education and Training
The Scientist names Fox Chase among the "Best Places to Work" for postdocs.
- Postdoctoral Research Program
- Graduate Student Program
- Clinical Fellowships
- Pre-Graduate Research Program
The Keystone Programs for Collaborative Discovery are a suite of innovative team-based cancer research initiatives launched by Fox Chase Cancer Center in February 2008.
At the heart of each Keystone Program is a self-organized group of scientists, clinicians, and other research professionals seeking to integrate and focus their joined expertise on a significant question in cancer. Read More ».
Clinical Trial Operations
Through performance of clinical trials, Fox Chase clinical researchers convert the insights from basic and translational research into the design and evaluation of new therapeutic regimens. Fox Chase Cancer Center has developed a large, centralized, and efficient infrastructure to support clinical trial efforts. Read More »
The SPORE in Ovarian Cancer is a National Cancer Institute-funded program for the prevention, diagnosis and treatment of ovarian cancer. Fox Chase is the only center in Pennsylvania and the first of only two facilities on the entire East Coast to receive a SPORE grant for ovarian cancer. The SPORE in Ovarian Cancer consists of six translational research projects that represent a diversity of objectives, including diagnosis, prevention, and treatment. Read More »
Begun in 2001, the American-Russian Cancer Alliance (ARCA) is a consortium of cancer research institutes led by Fox Chase for the purpose of bridging scientific research and medical education efforts between the two nations. ARCA affiliates include the University of Maryland-Greenebaum Cancer Center , N.N. Blokhin Cancer Center, and the Russian Research Centre-Kurchatov Institute, Russia's premier nuclear research center. The National Cancer Institute supports ARCA through a supplement to the Cancer Center Core Grant awarded to the Fox Chase Cancer Center.
Two main research initiatives have emerged through the consortium. The first leverages Russian expertise in the development of radioisotopes to create new diagnostic and therapeutic techniques for oncology. The second exports American population science research expertise to Russia, particularly as it relates to tobacco control research. Read More »